Cancer statistics, 2015

Each year the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data were collected by the National Cancer Institute (Surveillance, Epidemiology, and End Results [SEER] Program), the Centers for Disease Control and Prevention (National Program of Cancer Registries), and the North American Association of Central Cancer Registries. Mortality data were collected by the National Center for Health Statistics. A total of 1,658,370 new cancer cases and 589,430 cancer deaths are projected to occur in the United States in 2015. During the most recent 5 years for which there are data (2007‐2011), delay‐adjusted cancer incidence rates (13 oldest SEER registries) declined by 1.8% per year in men and were stable in women, while cancer death rates nationwide decreased by 1.8% per year in men and by 1.4% per year in women. The overall cancer death rate decreased from 215.1 (per 100,000 population) in 1991 to 168.7 in 2011, a total relative decline of 22%. However, the magnitude of the decline varied by state, and was generally lowest in the South (∼15%) and highest in the Northeast (≥20%). For example, there were declines of 25% to 30% in Maryland, New Jersey, Massachusetts, New York, and Delaware, which collectively averted 29,000 cancer deaths in 2011 as a result of this progress. Further gains can be accelerated by applying existing cancer control knowledge across all segments of the population. CA Cancer J Clin 2015;65:5–29. © 2015 American Cancer Society.

[1]  J. Duffus,et al.  Histology , 1931, The Indian Medical Gazette.

[2]  Rascon.  [The National Cancer Institute]. , 1953, Boletin cultural e informativo - Consejo General de Colegios Medicos de Espana.

[3]  Ruth P. Mack,et al.  Long-Term Trends , 2011 .

[4]  P. Trott,et al.  International Classification of Diseases for Oncology , 1977 .

[5]  J. Harris.  Cigarette Smoking Among Successive Birth Cohorts of Men and Women in the United States During 1900–1980 , 1983 .

[6]  J. Harris.  Cigarette smoking among successive birth cohorts of men and women in the United States during 1900-80. , 1983, Journal of the National Cancer Institute.

[7]  C. Muir,et al.  International Classification of Diseases for Oncology , 1990 .

[8]  L. Kessler,et al.  Rise in prostatic cancer incidence associated with increased use of transurethral resection. , 1990, Journal of the National Cancer Institute.

[9]  B A Miller,et al.  The role of increasing detection in the rising incidence of prostate cancer. , 1995, JAMA.

[10]  E. Feuer,et al.  Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.

[11]  Lisa M. Schwartz,et al.  Are increasing 5-year survival rates evidence of success against cancer? , 2000, JAMA.

[12]  A. Jemal,et al.  Breast Cancer Statistics , 2013 .

[13]  J. Fraumeni,et al.  Alternate ranging methods for cancer mortality maps. , 2000, Journal of the National Cancer Institute.

[14]  Hyune-Ju Kim,et al.  Kim H-J, Fay MP, Feuer EJ, Midthune DN, ‘ Permutation tests for joinpoint regression with applications to cancer rates’. Statistics in Medicine 2000 19:335–351 , 2001 .

[15]  E. Feuer,et al.  Impact of reporting delay and reporting error on cancer incidence rates and trends. , 2002, Journal of the National Cancer Institute.

[16]  P. Walsh.  Survival of blacks and whites after a cancer diagnosis. , 2002, The Journal of urology.

[17]  Ahmedin Jemal,et al.  Trends in Breast Cancer by Race and Ethnicity , 2003, CA: a cancer journal for clinicians.

[18]  Michael J Thun,et al.  Long‐term trends in cancer mortality in the United States, 1930–1998 , 2003, Cancer.

[19]  Ahmedin Jemal,et al.  Cancer Disparities by Race/Ethnicity and Socioeconomic Status , 2004, CA: a cancer journal for clinicians.

[20]  E. Feuer,et al.  The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence declinein the United States , 1998, Cancer Causes & Control.

[21]  D. Berry,et al.  Effect of screening and adjuvant therapy on mortality from breast cancer. , 2006, The New England journal of medicine.

[22]  D. Nerenz,et al.  Comorbidity and survival disparities among black and white patients with breast cancer. , 2005, JAMA.

[23]  D. Parkin,et al.  The global health burden of infection‐associated cancers in the year 2002 , 2006, International journal of cancer.

[24]  M. Goodman,et al.  Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992–2001 , 2006, Cancer.

[25]  E. Feuer,et al.  Changing patterns in breast cancer incidence trends. , 2006, Journal of the National Cancer Institute. Monographs.

[26]  Mark Hachey,et al.  A New Method of Estimating United States and State‐level Cancer Incidence Counts for the Current Calendar Year , 2007, CA: a cancer journal for clinicians.

[27]  Dante diTommaso,et al.  Quantifying the role of PSA screening in the US prostate cancer mortality decline , 2008, Cancer Causes & Control.

[28]  O. Carrasquillo,et al.  Racial/ethnic disparities in time to follow-up after an abnormal mammogram. , 2008, Journal of women's health.

[29]  Ari B. Friedman,et al.  The Reversal of Fortunes: Trends in County Mortality and Cross-County Mortality Disparities in the United States , 2008, PLoS medicine.

[30]  C. Gross,et al.  Racial disparities in cancer therapy , 2008, Cancer.

[31]  Xiao-Cheng Wu,et al.  Annual Report to the Nation on the Status of Cancer, 1975–2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control , 2008, Journal of the National Cancer Institute.

[32]  B. D. Proctor,et al.  Current Population Reports, P60-235, Income, Poverty, and Health Insurance Coverage in the United States: 2007 , 2008 .

[33]  Dawn L Hershman,et al.  Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. , 2009, Journal of the National Cancer Institute.

[34]  P. Rosenberg,et al.  Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis. , 2009, Journal of the National Cancer Institute.

[35]  Jacques Ferlay,et al.  Recent patterns in gastric cancer: A global overview , 2009, International journal of cancer.

[36]  Angela Mariotto,et al.  Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. , 2009, Journal of the National Cancer Institute.

[37]  A. Jemal,et al.  Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates , 2010, Cancer.

[38]  P. Rosenberg,et al.  Age-specific trends in incidence of noncardia gastric cancer in US adults. , 2010, JAMA.

[39]  Ahmedin Jemal,et al.  Breast cancer statistics, 2011 , 2011, CA: a cancer journal for clinicians.

[40]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[41]  P. Rosenberg,et al.  Divergent trends for gastric cancer incidence by anatomical subsite in US adults , 2011, Gut.

[42]  A. Jemal,et al.  Predicting US‐ and state‐level cancer counts for the current calendar year , 2012, Cancer.

[43]  A. Jemal,et al.  Predicting US‐ and state‐level cancer counts for the current calendar year , 2012, Cancer.

[44]  I. Tumur,et al.  Treatments for chronic myeloid leukemia: a qualitative systematic review , 2012, Journal of blood medicine.

[45]  T. Thompson,et al.  Recent trends in prostate cancer testing and incidence among men under age of 50. , 2012, Cancer epidemiology.

[46]  A. Jemal,et al.  Increasing lung cancer death rates among young women in southern and midwestern States. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  M. Roizen.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[48]  Ahmedin Jemal,et al.  Trends in Colorectal Cancer Incidence Rates in the United States by Tumor Location and Stage, 1992–2008 , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[49]  B. Kramer,et al.  The National Lung Screening Trial: Results stratified by demographics, smoking history, and lung cancer histology , 2013, Cancer.

[50]  L. Hou,et al.  Adult Stature and Risk of Cancer at Different Anatomic Sites in a Cohort of Postmenopausal Women , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[51]  J. Potter,et al.  Height as an explanatory factor for sex differences in human cancer. , 2013, Journal of the National Cancer Institute.

[52]  Carmen DeNavas-Walt,et al.  Income, Poverty, and Health Insurance Coverage in the United States: 2012. Current Population Reports P60-245. , 2013 .

[53]  D. Ekwueme,et al.  Prostate cancer screening in men ages 75 and older fell by 8 percentage points after Task Force recommendation. , 2013, Health affairs.

[54]  Jiaquan Xu,et al.  Deaths: final data for 2010. , 2013, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[55]  T. Holford,et al.  Tobacco Control and the Reduction in Smoking-Related Premature Deaths in the United States, 1964-2012 , 2014 .

[56]  T. Holford,et al.  Tobacco control and the reduction in smoking-related premature deaths in the United States, 1964-2012. , 2014, JAMA.

[57]  S. Eggener,et al.  National trends in prostate cancer screening among older American men with limited 9‐year life expectancies: Evidence of an increased need for shared decision making , 2014, Cancer.

[58]  David K. Espey,et al.  Disparities in cancer mortality and incidence among American Indians and Alaska Natives in the United States. , 2014, American journal of public health.